Figure 2. The PKC inhibitor chelerythine was given to determine whether any observed effect can be abolished. In addition, DiC8, a PKC analogue, was given to stimulate protein kinase C. (Circ Res 1995;77:1030-1035.)

Reprinted with permission from Lippincott Williams and Wilkins (www.lww.com).